Intra-rectal use of epinephrine in radiotherapy of prostate cancer

References

• Pollack A, Zagars GK, Starkschall G, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097–1105.12128107
   PubMed Web of Science ®Google Scholar
• Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294:1233–1239. doi:10.1001/jama.294.10.123316160131
   PubMed Web of Science ®Google Scholar
• Dearnaley DP, Jovic G, Syndikus I, et al. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol. 2014;15:464–473. doi:10.1016/S1470-2045(14)70040-324581940
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV. Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2009;73:685–691. doi:10.1016/j.ijrobp.2008.04.06318718725
   PubMed Web of Science ®Google Scholar
• Peeters ST, Heemsbergen WD, van Putten WL, et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005;61:1019–1034. doi:10.1016/j.ijrobp.2004.07.71515752881
   PubMed Web of Science ®Google Scholar
• Wortel RC, Incrocci L, Pos FJ, et al. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients. Int J Radiat Oncol Biol Phys. 2015;91:737–744. doi:10.1016/j.ijrobp.2014.12.01725752386
   PubMed Web of Science ®Google Scholar
• Wortel RC, Incrocci L, Pos FJ, et al. Late side effects after image guided intensity modulated radiation therapy compared to 3D-conformal radiation therapy for prostate cancer: results from 2 prospective cohorts. Int J Radiat Oncol Biol Phys. 2016;95:680–689. doi:10.1016/j.ijrobp.2016.01.03127055398
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, van Putten WL, Heemsbergen WD, et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;72:980–988. doi:10.1016/j.ijrobp.2008.02.07318495377
   PubMed Web of Science ®Google Scholar
• O‘Brien PC, Franklin CI, Dear KB, et al. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis. Radiother Oncol. 1997;45:117–123.9424000
   PubMed Web of Science ®Google Scholar
• Hille A, Schmidberger H, Hermann RM, et al. A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2005;63:1488–1493. doi:10.1016/j.ijrobp.2005.05.06316137837
   PubMed Web of Science ®Google Scholar
• Resbeut M, Marteau P, Cowen D, et al. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol. 1997;44:59–63.9288859
   PubMed Web of Science ®Google Scholar
• Athanassiou H, Antonadou D, Coliarakis N, et al. Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial. Int J Radiat Oncol Biol Phys. 2003;56:1154–1160.12829154
   PubMed Web of Science ®Google Scholar
• Kouloulias VE, Kouvaris JR, Pissakas G, et al. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Int J Radiat Oncol Biol Phys. 2005;62:486–493. doi:10.1016/j.ijrobp.2004.10.04315890591
   PubMed Web of Science ®Google Scholar
• Ben-Josef E, Han S, Tobi M, et al. A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. Int J Radiat Oncol Biol Phys. 2002;53:1160–1164.12128116
   PubMed Web of Science ®Google Scholar
• Singh AK, Ménard C, Guion P, et al. Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: A pilot study. Int J Radiat Oncol Biol Phys. 2006;65:1008–1013. doi:10.1016/j.ijrobp.2006.02.03016730138
   PubMed Web of Science ®Google Scholar
• Simone NL, Menard C, Soule BP, et al. Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in quality of life measured by EPIC score. Int J Radiat Oncol Biol Phys. 2008;70:90–95. doi:10.1016/j.ijrobp.2007.05.05717855015
   PubMed Web of Science ®Google Scholar
• Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015;92:971–977. doi:10.1016/j.ijrobp.2015.04.03026054865
   PubMed Web of Science ®Google Scholar
• Prewitt RL, Musacchia XJ. Mechanisms of radio-protection by catecholamines in the hamster (Mesocricetus auratus). Int J Radiat Biol Relat Stud Phys Chem Med. 1975;27:181–191.1079022
   PubMed Web of Science ®Google Scholar
• Steckel RJ, Tobin PL, Stein JJ, Bennett RL. Intra-arterial epinephrine protection against radiation nephritis. A Progress Report. Radiology. 1969;92:1341–1345.5790643
   PubMed Web of Science ®Google Scholar
• Gao X, Nakagawa T, Yamamoto M, et al. Radioprotective effect of epinephrine as a vasoconstrictor in mouse oral mucosa and scalp. Okayama Igakkai zasshi. 1996;108:139–144. doi:10.4044/joma1947.108.3-6_139
   Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346. doi:10.1016/0360-3016(95)00060-C7713792
   PubMed Web of Science ®Google Scholar